Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CFO

VP, Finance and Accounting

SVP, Chief Medical Officer

Chief Executive Officer

VP, Human Resources

SVP, Regulatory & QA

EVP, Innov & Chem Sciences

SVP, General Counsel & Secr.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-28	Premium	acquired	Premium	Premium	Premium	-
2024-04-28	Premium	acquired	Premium	Premium	Premium	-
2024-04-28	Premium	acquired	Premium	Premium	Premium	-
2024-04-28	Premium	acquired	Premium	Premium	Premium	-
2024-04-28	Premium	acquired	Premium	Premium	Premium	-
2024-04-28	Premium	acquired	Premium	Premium	Premium	-
2024-03-13	Premium	acquired	Premium	Premium	Premium	-
2024-02-28	Premium	acquired	Premium	Premium	Premium	President and CFO
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	VP, Finance and Accounting
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Chief Medical Officer
2024-02-28	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-02-28	Premium	acquired	Premium	Premium	Premium	VP, Human Resources
2024-02-28	Premium	acquired	Premium	Premium	Premium	VP, Finance and Accounting
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Regulatory & QA
2024-02-28	Premium	acquired	Premium	Premium	Premium	EVP, Innov & Chem Sciences
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	VP, Human Resources
2024-02-28	Premium	acquired	Premium	Premium	Premium	SVP, Regulatory & QA
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	President and CFO
2024-02-28	Premium	acquired	Premium	Premium	Premium	SVP, Chief Medical Officer
2024-02-28	Premium	acquired	Premium	Premium	Premium	SVP, General Counsel & Secr.
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	SVP, General Counsel & Secr.
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	EVP, Innov & Chem Sciences
2023-11-16	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-11-13	Premium	bought	Premium	Premium	Premium	-

LXRX - Lexicon Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for LXRX